Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

Exciting plans for this year’s Research Community Forum (RCF) Annual Meeting are highlighted in a new ASCO Connection blog post by RCF Steering Group Chair David Waterhouse, MD​, including presentations,  collaborative sessions, and a Keynote Address delivered by FDA Oncology Center of Excellence Director, Richard Pazdur, MD. Read the blog. 
The RCF myConnection page is a space for the research community to network and collaborate, discuss challenges, and share best practices virtually. Sign-in with your ASCO account to join now.
ASCO’s Center for Research and Analytics (CENTRA) is now accepting research applications from ASCO members who wish to conduct surveys of ASCO members for research purposes. Learn more about this important ASCO research initiative and you can help inform research in oncology.
In the latest ASCO in Action Podcast, ASCO President Dr. Monica Bertagnolli joined ASCO CEO Dr. Clifford Hudis to discuss the disparities facing patients with cancer in rural areas. Dr. Bertagnolli touched on a number of ways to close the rural cancer care gap, from supporting the existing rural oncology workforce, to improving care delivery in rural areas, and increasing access to clinical trials and research. “We’re completely in the dark without research,” says Dr. Bertagnolli. It’s “the only way to understand what patients really need.”
Positive findings from fully enrolled cohorts in non-small cell lung cancer and metastatic breast cancer from ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR™) Study will be presented in poster sessions at the 2019 ASCO Annual Meeting. In addition, the study is being expanded to include patients with active brain metastases and three new drug therapies. Learn more.
ASCO and Friends of Cancer Research (Friends) have commended the U.S. Food and Drug Administration (FDA) on four recently released draft guidance documents related to expanding clinical trial eligibility in a joint letter to Acting Commissioner Ned Sharpless, MD. Read more.
Early registration is now open for the ASCO Research Community Forum (RCF) 2019 Annual Meeting. The ASCO RCF Annual Meeting brings together physician investigators and research staff from across the country for two days of learning and collaboration. The meeting offers colleagues from a variety of types of research programs a unique platform to collaborate and develop solutions to common challenges with conducting oncology clinical trials.
Three completed cohorts reporting findings in non-small cell lung cancer, breast, and metastatic colorectal cancer from ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR™) Study were presented in poster sessions during AACR Annual Meeting 2019. In addition, all seven participating pharmaceutical companies renewed their commitment to provide study drugs at no cost. Learn more.